Autocrine nerve growth factor in human keratinocytes

Journal of Dermatological Science

Volumn 22, Issue 2, 2000, Pages 71-79

  Pincelli, Carlo ^a   Marconi, Alessandra ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Apoptosis; Bcl 2; Nerve growth factor; Proliferation; TrkA

Indexed keywords

MESSENGER RNA; NERVE GROWTH FACTOR; PROTEIN BCL 2; PROTEIN TYROSINE KINASE;

APOPTOSIS; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; REVIEW; SKIN CANCER; SKIN DISEASE; ULTRAVIOLET IRRADIATION;

APOPTOSIS; AUTOCRINE COMMUNICATION; HUMANS; KERATINOCYTES; NERVE GROWTH FACTOR;

EID: 0033991834     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(99)00065-1     Document Type: Review

References (87)

1. Snider W.D. Functions of the neurotrophins during nervous system development: what the knockout are teaching us. Cell. 77:1994;627-638.
2. Lewin G.R., Barde Y.A. The physiology of neurotrophins. Annu. Rev. Neurosci. 19:1996;289-317.
3. Yaar M., Eller M.S., DiBenedetto P., Reenstra W.R., Zhai S., McQuaid T. et al. The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes. J. Clin. Invest. 94:1994;1550-1562.
4. Pincelli C., Yaar M. Nerve growth factor: its significance in cutaneous biology. J. Invest. Dermatol. Symp. Proc. 2:1997;31-36.
5. Levi-Montalcini R., Meyer H., Hamburger V. In vitro experiments on the effects of mouse sarcomas 180 and 37 on the spinal and sympathetic ganglia of the chick embrio. Cancer Res. 14:1954;49-57.
6. Levi-Montalcini R. The nerve growth factor 35 years later. Science. 237:1987;1154-1162.
7. Matsuda H., Coughlin M.D., Bienenstock J., Denburg J.A. Nerve growth factor promotes human hemopoietic colony growth and differentiation. Proc. Natl. Acad. Sci. 85:1988;6508-6512.
8. Otten U., Ehrhard P., Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc. Natl. Acad. Sci. 86:1989;10059-10063.
9. Alheim K., Andersson C., Tingsborg S., Ziolkowska M., Schultzberg M., Bartfai T. Interleukin 1 expression is inducible by nerve growth factor in PC12 pheochromocytoma cells. Proc. Natl. Acad. Sci. 88:1991;9302-9306.
10. Braun A., Appel E., Baruch R., Herz U., Botchkarev V., Paus R. Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur. J. Immunol. 28:1998;3240-3251.
11. Welker P., Grabbe J., Grutzkau A., Henz B.M. Effects of nerve growth factor (NGF) and other fibroblast-derived growth factors on immature human mast cells (HMC-1). Immunology. 94:1998;310-317.
12. Lambiase A., Bracci-Laudiero L., Bonini S., Bonini S., Starace G., D'Elios M.M. Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. J. Allergy. Clin. Immunol. 100:1997;408-414.
13. Davies A.M., Bandtlow C., Heumann R., Korsching S., Rohrer H., Thoenen H. Timing and site of nerve growth factor synthesis in developing mouse skin in relation to innervation and expression of receptor. Nature. 326:1987;353-358.
14. Davis B.M., Fundin B.T., Albers K.M., Goodness T.P., Cronk K.M., Rice F.L. Over-expression of nerve growth factor in skin causes preferential increases among innervation to specific sensory targets. J. Comp. Neurol. 387:1997;489-506.
15. Goodness T.P., Albers K.M., Davis F.E., Davis B.M. Over-expression of nerve growth factor in skin increases sensory neuron size and modulates Trk receptor expression. Eur. J. Neurosci. 9:1997;1574-1585.
16. Tron V.A., Coughlin M.D., Jang D.E., Stanisz J., Sauder D.N. Expression and modulation of nerve growth factor in murine keratinocytes (Pam 212). J. Clin. Invest. 85:1990;1085-1089.
17. Yaar M., Grossman K., Eller M., Gilchrest B. Evidence for nerve growth factor-mediated paracrine effects in human epidermis. J. Cell. Biol. 115:1991;821-828.
18. Di Marco E., Marchisio P.C., Bondanza S., Franzi A.T., Cancedda R., De Luca M. Growth-regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes. J. Biol. Chem. 266:1991;21718-21722.
19. Pincelli C., Sevignani C., Manfredini R., Grande A., Fantini F., Bracci-Laudiero L. Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J. Invest. Dermatol. 103:1994;13-18.
20. Johnson D., Lanahan A., Randy Buck C., Sehgal A., Morgan C., Mercer E. Expression and structure of the human NGF receptor. Cell. 47:1986;545-554.
21. Kaplan D.R., Hempstead B.L., Martin-Zanca D., Chao M.V., Parada L.F. The trk protooncogene product: a signal transducing receptor for nerve growth factor. Science (Wash). 252:1991;554-558.
22. Bothwell M. Keeping track of neurotrophin receptors. Cell. 65:1991;915-918.
23. Barbacid M. Nerve growth factor: a tale of two receptors. Oncogene. 8:1993;2033-2042.
24. Klein R., Jing S., Nanduri V., O'Rourke E., Barbacid M. The trk protooncogene encodes a receptor for nerve growth factor. Cell. 65:1991;189-197.
25. Davies A. Neurotrophins: the Yin and Yang of nerve growth factor. Curr. Biol. 7:1997;38-40.
26. Hempstead B.L., Martin-Zanca D., Kaplan D.R., Parada L.F., Chao M.V. High-affinity NGF binding requires co-expressionof the trk proto-oncogene and low-affinity NGF receptor. Nature (Lond). 350:1991;678-683.
27. Ross A.H., Daou M.C., McKinnon C.A., Condon P.J., Lachyankar M.B., Stephens R.M. The neurotrophin receptor, gp 75, forms a complex with the receptor tyrosine kinase trkA. J. Cell. Biol. 132:1996;945-953.
28. Maliartchouk S., Saragovi U. Optimal nerve growth factor trophic signals mediated by synergy of trkA and p75 receptor-specific ligands. J. Neurosci. 17:1997;6031-6037.
29. Carter B.D., Kaltschmidt C., Kaltschmidt B., Offenhauser N., Bohm-Mattei R., Baeuerle P.A. Selective activation of NFkB by nerve growth factor throughthe neurotrophin receptor p75. Science. 272:1996;542-545.
30. Chapman B. A region of the 75kDa neurotrophin receptor homologous to the death domains of TNFR-I and Fas. FEBS Lett. 374:1995;216-220.
31. Schulze-Osthoff K., Ferrari D., Los M., Wesselborg S., Peter M.E. Apoptosis signaling by death receptors. Eur. J. Biochem. 254:1998;439-459.
32. Dobrowsky R.T., Werner M.H., Castellino A.M., Chao M.V., Hannun Y. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science. 265:1994;1569-1599.
33. Kaplan D.R., Miller F.D. Signal transduction by the neurotrophin receptors. Curr. Opin. Cell. Biol. 9:1997;213-221.
34. Zhai S., Pincelli C., Yaar M., Gonsalves J., Gilchrest B.A. The role of nerve growth factor in preventing keratinocyte apoptosis (abstract). J. Invest. Dermatol. 104:1995;572.
35. Di Marco E., Mathor M., Bondanza S., Cutuli N., Marchisio P.C., Cancedda R. Nerve growth factor binds to normal human keratinocytes through high and low affinity receptors and stimulates their growth by a novel autocrine loop. J. Biol. Chem. 268:1993;22838-22846.
36. Lesauteur L., Maliartchouk S., Le Jeune H., Quirion R., Saragovi H.U. Potent human p140-TrkA agaonists derived from an anti-receptor monoclonal antibody. J. Neurosci. 16:1996;1308-1316.
37. Barde Y.A. Trophic factors and neuronal survival. Neuron. 2:1989;1525-1534.
38. Raff M.C. Social controls on cell survival and cell death. Nature. 356:1992;397-400.
39. Haake A.R., Polakowska R.R. Cell death by apoptosis in epidermal cell biology. J. Invest. Dermatol. 101:1993;107-112.
40. Kannan Y., Usami K., Okada M., Shimizu S., Matsuda H. Nerve growth factor suppresses apoptosis of murine neutrophils. Biochem. Biophys. Res. Commun. 186:1992;1050-1056.
41. Torcia M., Bracci-Laudiero L., Lucibello M., Nencioni L., Labardi D., Rubartelli A. et al. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell. 85:1996;345-356.
42. Zhai S., Yaar M., Doyle S.M., Gilchrest B.A. Nerve growth factor rescues pigment cells from ultraviolet-induced apoptosis by upregulating BCL-2 levels. Exp. Cell. Res. 224:1996;335-343.
43. Pincelli C., Haake A.R., Benassi L., Grassilli E., Magnoni C., Ottani D. Autocrine nerve growth factor protects human keratinocytes from apoptosis through its high affinity receptor (trk): a role for bcl-2. J. Invest. Dermatol. 109:1997;757-764.
44. Budtz P.E. Tissue Kinetic Homeostasis: Studies on toad epidermis. 1991;August Krogh Publications, Copenhagen.
45. Polakowska R.R., Haake A.R. Apoptosis: the skin from a new perspective. Cell. Death. Differ. 1:1994;19-31.
46. King K.L., Cidlowski J.A. Cell cycle and apoptosis: common pathways to life and death. J. Cell. Biochem. 58:1995;175-180.
47. Pandey S., Wang E. Cells en route to apoptosis are characterized by the up-regulation of c-fos, c-myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell cycle traverse. J. Cell. Biochem. 58:1995;135-150.
48. Rubin L.L., Philpott K.L., Brooks S.F. The cell cycle and cell death. Curr. Biol. 3:1993;391-394.
49. Ucker D.S. Death by suicide: one way to go in mammalian cellular development? N. Biol. 3:1991;103-109.
50. Haake A.R., Polakowska R.R. UV-induced apoptosis in skin equivalents: inhibition by phorbol ester and Bcl-2 over-expression. Cell Death Differ. 2:1995;183-193.
51. Haake A.R., Roublevskaia I., Cooklis M. Apoptosis: a role in skin aging? J. Invest. Dermatol. Suppl. Proc. 3:1998;28-35.
52. Danno K., Horio T. Formation of UV-induced apoptosis relates to the cell cycle. Br. J. Dermatol. 107:1982;423-428.
53. Norris D.A., Middleton M.H., Whang K., Schleicher M., McGovern T., Bennion S.D. et al. Human keratinocytes maintain reversible anti-apoptotic defenses in vivo and in vitro. Apoptosis. 2:1997;136-148.
54. Yang E., Korsmeyer S.J. Molecular thanaptosis: a discourse on the bcl-2 family and cell death. Blood. 88:1996;386-401.
55. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med. 3:1997;614-620.
56. L. J. Biol. Chem. 271:1996;6306-6312.
57. Boise L.H., Thompson C.B. Bcl-x (L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc. Ntl. Acad. Sci. 94:1997;3759-3764.
58. Torcia M., Bracci-Laudiero L., Lucibello M., Nencioni L., Labardi D., Rubartelli A. et al. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell. 85:1996;345-356.
59. Zhai S., Yaar M., Doyle S.M., Gilchrest B.A. Nerve growth factor rescues pigment cells from ultraviolet-induced apoptosis by upregulating BCL-2 levels. Exp. Cell. Res. 224:1996;335-343.
60. Vogelbaum M.A., Tang J.X., Rich K.M. Developmental regulation of apoptosis in dorsal root ganglion neuron. J. Neurosci. 18:1998;8928-8935.
61. Miyaji E.N., Menck C.F. Human Bcl-2 expression delays ultraviolet-induced apoptosis in marsupial cells. Photochem. Photobiol. 68:1998;719-724.
62. Martin S.J., Newmeyer D.D., Mathias S., Farscon D.M., Wang H.G., Reed J.C. et al. Cell-free reconstitution of Fas-, UV radiation- and ceramide-induced apoptosis. EMBO J. 14:1995;5191-5200.
63. Gillardon F., Eschenfelder C., Uhlman E., Hartschuh W., Zimmerman M. Differential regulation of c-fos, fosB, c-jun, junB, bcl-2 and bax expression in rat skin following single or chronic unltraviolet irradiation and in vivo modulation by antisense oligodeoxynucleotide superfusion. Oncogene. 9:1994;3210-3225.
64. Pena J.C., Fuchs E. Thompson CB: Bcl-x expression influences keratinocyte cell survival but not terminal differentiation. Cell Growth Differ. 8:1997;619-629.
65. O'Grady A., Kay E.W., McKenna D.B., Bennett M.A., Murphy G.M., Leader M.B. Altered expression of the p53-regulated proteins, p21Waf1/Cip1, MDM2, and Bax in ultraviolet-irradiated human skin. Human. Pathol. 29:1998;559-564.
66. Rodriguez-Villanueva J., Greenhalgh D., Wang X.J., Bundman D., Cho S., Delehedde M. et al. Human keratin-1 bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation. Oncogene. 16:1998;853-863.
67. Yee N.S., Paek I., Besmer P. Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: basis for radiosensitivity of white spotting and steel mutant mice. J. Exp. Med. 179:1994;1777-1787.
68. Budtz P.E. Epidermal homeostasis: a new model that includes apoptosis. Tomei L.D., Cope F.O. Apoptosis II: the Molecular Basis of Apoptosis in Disease. 1994;165-185 Cold Spring Harbor Laboratory Press Cold Spring Harbor, New York.
69. Goldsmith L.A. Toads and Psoriasis. Arch. Dermatol. 122:1986;939-940.
70. Wrone-Smith T., Johnson T., Nelson B., Boise L.H., Thompson C.B., Nunez G. et al. Discordant expression of bcl-x and bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo. Am. J. Pathol. 146:1995;1079-1088.
71. Gutierrez-Stei C., Wrone-Smith T., Sun X., Krueger J.G., Coven T., Nickoloff B.J. Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L). J. Clin. Invest. 101:1998;33-39.
72. Wrone-Smith T., Mitra R.S., Thompson C.B., Jasty R., Castle V.P., Nickoloff B.J. Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin. Am. J. Pathol. 151:1997;1321-1329.
73. Heenen M., Laporte M., Noel J.C., de Graef C. Methotrexate induces apoptotic cell death in human keratinocytes. Arch. Dermatol. Res. 290:1998;240-245.
74. Lin X.R., Wilkinson D.I., Farber E.M. Camptothecin induces differentiation, tissue transglutaminase and apoptosis in cultured keratinocytes. Exp. Dermatol. 7:1998;179-183.
75. Fantini F., Magnoni C., Bracci-Laudiero L., Pincelli C. Nerve growth factor is increased in psoriatic skin. J. Invest. Dermatol. 105:1995;854-855.
76. Raychaudhuri S.P., Jiang W.Y., Farber E.M. Psoriatic keratinocytes express high levels of nerve growth factor. Acta. Derm. Venereol. 78:1998;84-86.
77. 125I-epidermal growth factor binding and receptor distribution in psoriasis. J. Invest. Dermatol. 86:1986;260-265.
78. Favrot M., Coll J.-L., Louis N., Negoescu A. Cell death and cancer: replacement of apoptotic genes and inactivation of death suppressor genes in therapy. Gene Therapy. 5:1998;728-739.
79. Sarraf C.E., Bowen I.D. Proportions of mitotic and apoptosis cells in a range of untreated experimental tumors. Cell. Tiss. Kinet. 21:1988;45-49.
80. Delsite R., Djakiew D. Anti-proliferative effect of the kinase inhibitor K252a on human prostatic carcinoma cell lines. J. Androl. 17:1996;481-490.
81. GlosterJr H.M., Brodland D.G. The epidemiology of skin cancer. Dermatol. Surg. 22:1996;217-226.
82. Kripke M.L. Carcinogenesis: ultraviolet radiation. Fitzpatrick T.B., Eisen A.Z., Wolff K., Freedberg I., Austen K. Dermatology in General Medicine. 4th ed. 1993;796-804 McGraw-Hill, NewYork.
83. Shea C.R., Parrish J.A. Non-ionizing radiation and the skin. Goldsmith L.A. Physiology, Biochemistry and Molecular Biology of the Skin. 1991;910-927 Oxford University Press, NewYork.
84. Jonason A.S., Kunala S., Price G.J., Restifo R.J., Spinelli H.M., Persing J.A. et al. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc. Natl. Acad. Sci. 93:1996;14025-14029.
85. Ziegler A., Jonason A.S., Leffel D.J., Simon J.A., Sharma H.W., Kimmelman J. et al. Sunburn and p53 in the onset of skin cancer. Nature. 372:1994;773-776.
86. Kraemer K.H. Sunlight and skin cancer: another link revealed. Proc. Natl. Acad. Sci. 94:1997;11-14.
87. Kemp C.J., Donehower L.A., Bradley A., Balmain A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell. 74:1993;813-822.